Stockreport

Taysha Gene Therapies Second Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag [Yahoo! Finance]

Taysha Gene Therapies, Inc.  (TSHA) 
PDF Net loss: US$20.9m (loss narrowed by 15% from 2Q 2023). US$0.09 loss per share (improved from US$0.38 loss in 2Q 2023). All figures shown in the chart above are for [Read more]